Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 29;13(1):57.
doi: 10.1186/s40035-024-00451-8.

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer's disease

Affiliations

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer's disease

Nerea Gómez de San José et al. Transl Neurodegener. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The studies obtained approval from respective ethics committees (Ulm University Hospital, No. 20/10; University Perugia, 19369/08/AV registry no: 1287/08 date: 9 October 2008 and University of Turin, 0114576) and adhered to the most recent iteration of the Declaration of Helsinki. Prior to participation, all the participants or their caregivers received a thorough explanation of the study's procedures and gave written consent. Consent for publication: Not applicable. Competing interests: Dr. Gaetani participated on advisory boards for, and received writing honoraria and travel grants from Almirall, Biogen, Euroimmun, Fujirebio, Lilly, Merck, Mylan, Novartis, Roche, Sanofi, Siemens Healthineers and Teva.

Figures

Fig. 1
Fig. 1
Aquaporin 4 (AQP4) CSF analysis in three different cohorts. CSF AQP4 in the discovery cohort (n = 157) including 38 CON, 40 AD, 21 PPA, 20 bvFTD, 17 ALS and 21 LBD (a, b) and in the validation cohorts I and II: cohort I (n = 108) including 37 CON, 14 preAD, 28 AD-MCI and 29 ADD (c, d) and cohort II (n = 68) including 18 CON, 23 AD-MCI, 10 ADD and 17 non-AD MCI (e, f). Boxplots represent median, Q1 and Q3 quartiles, and whiskers from minimum to maximum. *P < 0.05, **P < 0.01, and ***P < 0.001. b, d, f Receiver operating characteristics curve analysis of CSF AQP4. AD, Alzheimer’s disease; ALS; amyotrophic lateral sclerosis; AUC, area under the curve; bvFTD, behavioral variant frontotemporal dementia; CON, control; CSF, cerebrospinal fluid; IQR, interquartile range; LBD, Lewy body disease; PPA, primary progressive aphasia

References

    1. Blennow K, Zetterberg H. Biomarkers for Alzheimer’s disease: current status and prospects for the future. J Intern Med. 2018;284(6):643–63. - PubMed
    1. Zenaro E, Piacentino G, Constantin G. The blood-brain barrier in Alzheimer’s disease. Neurobiol Dis. 2017;107:41–56. - PMC - PubMed
    1. Wildsmith KR, Holley M, Savage JC, Skerrett R, Landreth GE. Evidence for impaired amyloid beta clearance in Alzheimer’s disease. Alzheimers Res Ther. 2013;5(4):33. - PMC - PubMed
    1. Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci. 1997;17(1):171–80. - PMC - PubMed
    1. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. 2012;4(147):147ra111. - PMC - PubMed

LinkOut - more resources